FDG PET/CT to detect bone marrow involvement in the initial staging of patients with aggressive non-Hodgkin lymphoma: results from the prospective, multicenter PETAL and OPTIMAL>60 trials

PURPOSE: Fluorine-18 fluorodeoxyglucose positron emission tomography combined with computed tomography (FDG PET/CT) is the standard for staging aggressive non-Hodgkin lymphoma (NHL). Limited data from prospective studies is available to determine whether initial staging by FDG PET/CT provides treatm...

Descripción completa

Detalles Bibliográficos
Autores principales: Kaddu-Mulindwa, Dominic, Altmann, Bettina, Held, Gerhard, Angel, Stephanie, Stilgenbauer, Stephan, Thurner, Lorenz, Bewarder, Moritz, Schwier, Maren, Pfreundschuh, Michael, Löffler, Markus, Menhart, Karin, Grosse, Jirka, Ziepert, Marita, Herrmann, Ken, Dührsen, Ulrich, Hüttmann, Andreas, Barbato, Francesco, Poeschel, Viola, Hellwig, Dirk
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8440256/
https://www.ncbi.nlm.nih.gov/pubmed/33928400
http://dx.doi.org/10.1007/s00259-021-05348-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8440256/
https://www.ncbi.nlm.nih.gov/pubmed/33928400
http://dx.doi.org/10.1007/s00259-021-05348-6

Ejemplares similares